Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |